SCR-1481B1 ( c-Met inhibitor 2 )

产品货号. M20163 CAS No. 1174161-86-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

SCR-1481B1
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
产品描述

SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
同义词

c-Met inhibitor 2
通路

Angiogenesis
靶点

VEGFR
受体

VEGFR1
研究领域

——
适应症

——

CAS Number

1174161-86-4
分子量

742.07
分子式

C31H35ClF2N5O10P?
纯度

>98% (HPLC)
溶解度

DMSO:31 mg/mL?(44.29 mM)
SMILES

NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl
化学全称

——

1.Robert M. Borzilleri et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.

计算器

产品手册

关联产品

Takeda-6d

Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively.
Cabozantinib

Cabozantinib (XL184, BMS-907351) is a potent multi-kinase inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50 of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.
Lariciresinol

Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.